NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

LORA-PITA IV General Investigation

CompletedN/A

Sponsor: Pfizer

Conditions: Status Epilepticus

Interventions: Lorazepam

Countries: Japan

Secondary Data Collection:To confirm the effectiveness and safety profiles under the actual medical practice of LORA-PITA in Japan.

Eligibility overview

Sex: ALL

Age: 3 Months to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria: Patients administered Lorazepam in accordance with the indication (for Status Epilepticus) and have no history of using this drug.

Locations (1)

Tokyo, Shibuya-ku, Japan